Bioventus Inc. (BVS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 495.67M |
| Enterprise Value | 755.78M |
| P/E Ratio | 18.62 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 1.76 |
| Price/Book Ratio | 4.45 |
| Enterprise/Revenue | 2.16 |
| Enterprise/EBITDA | 12.11 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 27, 2026 |
Profitability
| Profit Margin | 0.09 |
| Operating Margin | 0.11 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.28 |
Income Statement
| Revenue | 568.09M |
| Revenue/Share | 8.57 |
| Gross Profit | 382.43M |
| EBITDA | 99.21M |
| Net Income | 22.73M |
| Diluted EPS | 0.33 |
Balance Sheet
| Total Cash | 29.46M |
| Total Cash/Share | 0.43 |
| Total Debt | 263.75M |
| Total Debt/Equity | 1.16 |
| Current Ratio | 1.69 |
| Book Value Per Share | 4.09 |
Price History
| 52-Week Change | 114.94 |
| 52-Week High | 15.89 |
| 52-Week Low | 6.47 |
| Moving Average 50 Days | 13.67 |
| Moving Average 200 Days | 10.7 |
Statistics
| Average Volume | 586,010 |
| Shares Outstanding | 68.31M |
| % Held by Institutions | 79.92 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
